Idelle V. Aschen, MD
PM&R Resident Physician
NewYork-Presbyterian - Cornell/Columbia
New York, New York, United States
Caitlyn Ko, MD
Resident Physician
New York Presbyterian Columbia/Cornell
New York, New York, United States
Jaclyn H. Bonder, MD
Medical Director, Women's Health Rehabilitation; Associate Chair for Medical Student Education
Weill Cornell Medicine
new york, New York, United States
Physical exam two months after initial visit while on pregabalin was significant for tenderness to palpation over internal and external bilateral transverse perineal muscles, mildly increased internal pelvic floor muscle resting tone, and no allodynia or hyperesthesia.
Lumbar spine MRI showed spondylosis without nerve compression, and pelvis MRI demonstrated right-sided ovarian varicosities and cysts but no other acute findings. Patient was uptitrated on pregabalin which provided improvement in vaginal pain but minimal improvement in extremity pain.
Conclusions: Post-COVID neuropathic pain due to small fiber neuropathy (SFN) presents several weeks after infection and causes significant disability due to painful paresthesias, allodynia, and numbness in extremities, abdomen, or face. It is hypothesized that the inflammatory immune response during a viral illness leads to immune dysregulation and small fiber nerve damage. This case presents a unique case of painful perineal symptoms, which has not been commonly seen with post-COVID SFN. Studies have looked at IVIG treatment, however this patient showed a positive response to pregabalin.
Post-COVID perineal neuralgia syndrome can affect quality of life; therefore, accurate diagnosis and treatment are necessary for functional recovery. Patients should be closely evaluated for symptoms to ensure adequate treatment is initiated.